Belma, Baby Girl -.
HRN: 26 10 02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/23/2024
10/30/2024
IV
75mg
Q24H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes